Adaptimmune Therapeutics Plc (ADAPY)
Adaptimmune Therapeutics Market Cap: 7.421M for Jan. 16, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Biodexa Pharmaceuticals Plc | 1.879M |
| NuCana Plc | 13.78M |
| Autolus Therapeutics Plc | 367.28M |
| Mereo BioPharma Group Plc | 101.76M |
| Bicycle Therapeutics Plc | 451.58M |
Market Cap Related Metrics
| PS Ratio | 0.1101 |
| PEG Ratio | -0.0005 |
| Price | 0.028 |
| Earnings Yield | -2.35K% |
| PEGY Ratio | -0.0005 |